A recent study led by Johns Hopkins Bloomberg School of Public Health researchers discovered that signs of common illnesses in a sample of middle-aged and older persons were associated with lower performance on a test of global cognitive function.
The Institute of Psychiatry, Psychology, and Neuroscience (IoPPN) at King's College London has developed a blood-based test that can predict the risk of Alzheimer's disease up to 3.5 years before clinical diagnosis.